Immatics (IMTX) Depreciation & Amortization (CF) (2019 - 2025)

Immatics (IMTX) posted Depreciation & Amortization (CF) of $3.7 million for Q4 2025, up 2.95% sequentially from $3.6 million in Q3 2025, and up 12.23% YoY from $3.3 million in Q4 2024.

Immatics (IMTX) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends

Immatics has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $3.7 million in Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 12.23% year-over-year to $3.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.0 million (up 5.8% YoY) and the FY2025 annual result came in at $14.0 million, up 5.88% from the prior year.
  • Depreciation & Amortization (CF) improved to $3.7 million in Q4 2025 per IMTX's latest filing, from $3.6 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.7 million in Q4 2025 and troughed at -$5.8 million in Q4 2023.
  • A 5-year average of $2.0 million and a median of $2.0 million in 2021 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) tumbled 427.09% in 2023, then jumped 156.32% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $1.5 million in 2021, then increased by 20.64% to $1.8 million in 2022, then sank by 427.09% to -$5.8 million in 2023, then surged by 156.32% to $3.3 million in 2024, then rose by 12.23% to $3.7 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.7 million, $3.6 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.10 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 40.52 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.18 Mn
10 Immatics 1.27 Bn 719.31 Mn - 3.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.69 Mn
Dec 31, 2025 3.69 Mn
Sep 30, 2025 3.58 Mn
Sep 30, 2025 3.58 Mn
Jun 30, 2025 3.43 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 3.30 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 3.29 Mn
Dec 31, 2024 3.29 Mn
Sep 30, 2024 3.33 Mn
Sep 30, 2024 3.33 Mn
Jun 30, 2024 3.34 Mn
Jun 30, 2024 3.34 Mn
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 -5.84 Mn
Dec 31, 2023 -5.84 Mn
Sep 30, 2023 1.92 Mn
Sep 30, 2023 1.92 Mn